Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29435931 | 1.00 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL22203096 | 0.95 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL30532297 | 0.95 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL22203245 | 0.90 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL29435962 | 0.90 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL22203242 | 0.88 | SCN8A (0.46) | SCN8ASCN10A | |
| SCHEMBL29435943 | 0.88 | SCN8A (0.46) | SCN8ASCN10A | |
| SCHEMBL30532310 | 0.85 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL22203099 | 0.85 | SCN8A (0.45) | SCN8ASCN10A | |
| SCHEMBL30712385 | 0.84 | SCN8A (0.44) | SCN8ASCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112955436-B | 6-oxo-1, 6-dihydropyridazine derivatives, preparation method and application thereof in medicines | 福建盛迪医药有限公司 | 2023-08-11 | — | — | CN | disclosed |
| EP-3907218-A1 | 6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2021-11-10 | — | — | EP | disclosed |
| CN-112955436-A | 6-oxo-1, 6-dihydropyridazine derivatives, preparation method and application thereof in medicines | 江苏恒瑞医药股份有限公司 | 2021-06-11 | — | — | CN | disclosed |
| WO-2020140959-A1 | 6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2020-07-09 | — | — | WO | disclosed |